VIT
vs
S
S&P/ASX 300
VIT
Over the past 12 months, VIT has underperformed S&P/ASX 300, delivering a return of -28% compared to the S&P/ASX 300's +3% growth.
Stocks Performance
VIT vs S&P/ASX 300
Performance Gap
VIT vs S&P/ASX 300
Performance By Year
VIT vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Vitura Health Ltd
Glance View
Vitura Health Ltd. operates as a medicinal cannabis company. The firm through its wholly owned subsidiary, CDA Health Pty Ltd, operates businesses, such as Burleigh Heads Cannabis and CDA Clinics. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes approximately 200 product stock-keeping units (SKUs) within Australia from 30 international and domestic medicinal cannabis producers. CDA Clinics undertakes telehealth consultations with patients seeking access to medicinal cannabis. Its portfolio of brands includes CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc and Adaya. The firm owns 75.5% of Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes nationwide telehealth consultations with patients seeking access to medicinal cannabis.
